查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1302509

連續腎臟替代治療市場：按產品、療法、方式和最終用戶 - 全球預測 2023-2030

Continuous Renal Replacement Therapy Market by Product, Therapy, Modality, End User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到2023年，全球持續腎臟替代治療市場規模將達到185億美元，年複合成長率為8.53%，預計將在2030年達到328.8億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球連續性腎臟替代治療市場至關重要。通過檢查業務戰略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的具體需求做出明智的資訊。這種高級分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市場佔有率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、積累和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通貨膨脹的累積影響。

5、競爭評估與資訊：對主要企業的市場佔有率、戰略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評價。

6. 產品開發和創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.持續性腎臟替代治療的全球市場規模和預測是多少？

2.在預測期內，COVID-19對全球連續性腎臟替代治療市場的抑制要素和影響有哪些？

3.在預測期內，全球連續性腎臟替代治療市場需要投資哪些產品/細分市場/應用/領域？

4、全球連續性腎臟替代治療市場的競爭策略是什麼？

5. 全球連續性腎臟替代治療市場的技術趨勢和法律規範是什麼？

6.全球連續性腎臟替代治療市場主要供應商的市場佔有率是多少？

7. 哪些型態和戰略舉措被認為適合進入全球連續性腎臟替代治療市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 急性腎損傷（AKI）發生率增加
      • 體外治療技術的進步
      • CRRT 間歇性血液淨化的臨床效益猛增
    • 抑制因素
      • 連續腎臟替代治療程序需要高昂的費用
    • 機會
      • 持續研發以提高 CRRT 的安全性和有效性
      • 兒科患者 CCRT 系統的開發
    • 課題
      • 與連續腎臟替代治療相關的技術問題
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通貨膨脹的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 連續腎臟替代治療市場：副產品

  • 譜系集
  • 透析液和置換液
  • 拋棄式用品
  • 血液過濾器
  • 系統

第7章 按治療方法分類的連續腎臟替代治療市場

  • 非腎性的
  • 腎

第8章 按方式分類的連續腎臟替代治療市場

  • 連續性靜脈-靜脈血液透析濾過
  • 連續性靜脈-靜脈血液透析
  • 連續靜脈靜脈血液濾過
  • 低速連續超過濾

第9章 連續腎臟替代治療市場：按最終用戶分類

  • 透析診所
  • 住宅
  • 醫院

第10章 美洲連續腎臟替代治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區持續腎臟替代治療市場

  • 澳大利亞
  • 中國
  • 印度
  • 印度尼西亞
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲連續腎臟替代治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 競爭情景分析：主要企業

第14章上市公司名單

第15章附錄

  • 討論指南
  • 關於許可和定價
Product Code: MRR-433AB1DC293B

The Global Continuous Renal Replacement Therapy Market is forecasted to grow significantly, with a projected USD 18.50 billion in 2023 at a CAGR of 8.53% and expected to reach a staggering USD 32.88 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Continuous Renal Replacement Therapy Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Continuous Renal Replacement Therapy Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Bloodline Sets, Dialysates & Replacement Fluids, Disposables, Hemofilters, and Systems. The Systems is projected to witness significant market share during forecast period.

Based on Therapy, market is studied across Non-renal and Renal. The Non-renal is projected to witness significant market share during forecast period.

Based on Modality, market is studied across Continuous Venovenous Hemodiafiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemofiltration, and Slow Continuous Ultrafiltration. The Slow Continuous Ultrafiltration is projected to witness significant market share during forecast period.

Based on End User, market is studied across Dialysis Clinics, Homes, and Hospitals. The Hospitals is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Continuous Renal Replacement Therapy Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Continuous Renal Replacement Therapy Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Continuous Renal Replacement Therapy Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Continuous Renal Replacement Therapy Market?

4. What is the competitive strategic window for opportunities in the Global Continuous Renal Replacement Therapy Market?

5. What are the technology trends and regulatory frameworks in the Global Continuous Renal Replacement Therapy Market?

6. What is the market share of the leading vendors in the Global Continuous Renal Replacement Therapy Market?

7. What modes and strategic moves are considered suitable for entering the Global Continuous Renal Replacement Therapy Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Continuous Renal Replacement Therapy Market, by Product, 2022 vs 2030
  • 4.3. Continuous Renal Replacement Therapy Market, by Therapy, 2022 vs 2030
  • 4.4. Continuous Renal Replacement Therapy Market, by Modality, 2022 vs 2030
  • 4.5. Continuous Renal Replacement Therapy Market, by End User, 2022 vs 2030
  • 4.6. Continuous Renal Replacement Therapy Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidences of acute kidney injury (AKI)
      • 5.1.1.2. Increasing technological advancement in the extracorporeal therapies
      • 5.1.1.3. Surging clinical advantages of CRRT over intermittent blood purification
    • 5.1.2. Restraints
      • 5.1.2.1. Need for massive cost for continuous renal replacement therapy procedure
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research and development for enhanced safety and efficacy of CRRT
      • 5.1.3.2. Developments of CCRT systems for pediatric patients
    • 5.1.4. Challenges
      • 5.1.4.1. Technical complications associated with continuous renal replacement therapy
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Continuous Renal Replacement Therapy Market, by Product

  • 6.1. Introduction
  • 6.2. Bloodline Sets
  • 6.3. Dialysates & Replacement Fluids
  • 6.4. Disposables
  • 6.5. Hemofilters
  • 6.6. Systems

7. Continuous Renal Replacement Therapy Market, by Therapy

  • 7.1. Introduction
  • 7.2. Non-renal
  • 7.3. Renal

8. Continuous Renal Replacement Therapy Market, by Modality

  • 8.1. Introduction
  • 8.2. Continuous Venovenous Hemodiafiltration
  • 8.3. Continuous Venovenous Hemodialysis
  • 8.4. Continuous Venovenous Hemofiltration
  • 8.5. Slow Continuous Ultrafiltration

9. Continuous Renal Replacement Therapy Market, by End User

  • 9.1. Introduction
  • 9.2. Dialysis Clinics
  • 9.3. Homes
  • 9.4. Hospitals

10. Americas Continuous Renal Replacement Therapy Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Continuous Renal Replacement Therapy Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Continuous Renal Replacement Therapy Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET RESEARCH PROCESS
  • FIGURE 2. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2022 VS 2030
  • FIGURE 3. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2022 VS 2030 (%)
  • FIGURE 6. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2022 VS 2030 (%)
  • FIGURE 7. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2022 VS 2030 (%)
  • FIGURE 8. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 9. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET DYNAMICS
  • FIGURE 10. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 19. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY BLOODLINE SETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DIALYSATES & REPLACEMENT FLUIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HEMOFILTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 11. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY NON-RENAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY RENAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 14. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIAFILTRATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMOFILTRATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY SLOW CONTINUOUS ULTRAFILTRATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 19. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DIALYSIS CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 190. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 191. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 192. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET LICENSE & PRICING